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Objective: To describe a demand estimation exercise conducted in response to an initiative to introduce Sayana
Press in Sub-Saharan Africa and South Asia.Methods: Secondary data sources were used to develop estimates
of the number of Sayana Press units needed for countrywide introductions in 12 countries. To estimate uptake,
the number of women who had stated an intention to use injectables was calculated. Two sets of assumptions
(one conservative, one more ambitious) were used to assess conversion to actual use. Results: Even with the
use of very conservative assumptions, and assuming no method switching, Sayana Press was estimated to
have the potential to cumulatively reach 3–6 million women by 2016. Conclusion: This projected uptake in a
relatively short period and at the very beginning of an adoption curve suggests that Sayana Press has promise
for countries looking to expand their list of contraceptive choices.
© 2015 Published by Elsevier Ireland Ltd. on behalf of International Federation of Gynecology and Obstetrics.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Improved access to, and use of, contraceptive methods has resulted
in steep declines in fertility since the 1960s [1]. Modeling estimates
indicate that contraceptive use averted 44% of maternal deaths in 2008
[2]. However, the same estimates projected that a further 29% of mater-
nal deaths could be averted annually if unmet needs for contraception
weremet [2]. An estimated 222millionwomen in low-income countries
have an unmet need formodern contraception [3]. It has been estimated
that this unmet need contributes to 7.4 million disability-adjusted
life years [4]. Although there has been a decline in unmet need for
contraception in low-income countries overall, this decrease has been
uneven,with a plateauing observed in SouthAsia and in 69 of theworld’s
poorest countries [3].
Despite proven beneﬁts for individuals and societies, the success of
family planning programs in reaching women in need in low-income
countries has been mixed. At a global level, growing populations and
demand for contraceptive commodities, coupled with stagnation in
donor support, have meant an increasing “donor gap” [5], meaning
that countries have not been able to meet funding requirements for
contraceptive commodities. For women, this often translates into a
restricted list of contraceptive options, both in terms of the number of
options offered in the mix and the availability of each method, which
is an important predictor of method continuation [6].98109, USA. Tel.: +1 206 302
behalf of International Federation oInjectables are a popular contraceptive method, particularly in
Sub-Saharan Africa: between 2000 and 2005, the share of injectables
in the method mix rose from 8% to 26% in the region, concomitant
with a smaller increase in total contraceptive prevalence [7]. Sayana
Press (Pﬁzer, NewYork, NY, USA) is a newpresentation and formulation
of depot medroxyprogesterone acetate (DMPA) in the Uniject device
(BD, Franklin Lakes, NJ, USA), which is an all-in-one, preﬁlled, auto-
disable injection system (Fig. 1). It combines the advantages of DMPA
with the added potential to reach greater numbers of women by
improving safety and ease of injection, and to enhance access through
non-clinic channels. In limited pilots, it has been found to be highly
acceptable among women and their providers [8].
As part of the commitments made at the London Summit on Family
Planning to expand access to family planning services in the world’s
poorest countries by 2020 [9], public and private partners announced
plans to reach women in Sub-Saharan Africa and South Asia with up
to 12 million doses of Sayana Press. The present report describes a
demand estimation exercise that was conducted in response to this
Sayana Press pilot introduction initiative. These estimates were
developed for two purposes: (1) to inform discussions among donors
and suppliers concerning the potential scope of, and locations for, pilot
introduction of Sayana Press; and (2) to contribute to the broader Family
Planning 2020metrics by establishing the contribution that Sayana Press
could make to the goal of reaching new users of contraceptives by 2020.
This initial estimation exercise covered 12 countries andwas complet-
ed between 2012 and 2013. It helped to guide discussions at the begin-
ning of the planning cycle on ﬁnal country identiﬁcation, selection, and
where the new method could have most promise to reach women. Asf Gynecology and Obstetrics. This is an open access article under the CC BY-NC-ND license
Fig. 1. Sayana Press. Photo Credit: PATH/Patrick McKern.
Table 1
Assumptions for annual conversion of intent to use contraception to actual use.
Countries Conversion to Sayana Press use by non-users who
intend to use injectables
Conservative scenario Ambitious scenario
Five countries with
start in fourth
quarter of 2013
• 2013: 1% converts
• 2014–2016: An additional
2% converts each year
• 2013: 5% converts
• 2014: An additional
2.5% converts
• 2015–2016: An additional
1.5% converts each year
Seven countries
with start in third
quarter of 2014
• 2014: 2% converts
• 2015: An additional
3% converts
• 2016: An additional
2% converts
• 2014: 5% converts
• 2015: An additional
4% converts
• 2016: An additional
1.5% converts
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countries: Burkina Faso, Niger, Senegal, and Uganda. The present report
will brieﬂy discuss how metrics estimation for this more restricted pilot
compared with the more expansive process.
As part of continuing conversations for countrywide introduction,
potential unit demand for Sayana Press and order volumes were
estimated at the very beginning of the planning cycle. The results are
measured in Sayana Press units rather than number of women reached,
which reﬂects the central purpose of this exercise. In addition, this
exercise initially estimated Sayana Press units needed for a countrywide
introduction in each setting—the intent being to initiate the estimation
processes across a diverse range of settings. Finally, the estimation
process also covers a larger number of countries than those in which
Sayana Press is currently being introduced.
2. Materials and methods
Traditionally, trend data (from historical logistics data or service
statistics) are used to project future demand [10]. New and underused
methods pose a unique challenge in estimation of demand because of
the lack of historical data. Sayana Press represents a hybrid between a
new and established contraceptive commodity because it could be con-
sidered a line extension of DMPA. However, because Sayana Pressmight
be easier to distribute through a more diverse array of channels,
facilities, and providers, it offers the potential to expand reach to new,
hitherto unreached populations. Because therewere no historic distribu-
tion and use data available for Sayana Press, estimates were developed
using secondary data, with embedded assumptions for estimating
potential demand for a countrywide introduction. All calculations were
done using Microsoft Excel (Microsoft, Redmond, WA, USA).
From the list of 60 Family Planning Summit priority countries, 14
countries were shortlisted on the basis of where PATH had signiﬁcant
presence, where previous landscaping work had been conducted for
Sayana Press, or which ones had been identiﬁed by donors as high pri-
ority. Of these, 12 were then selected for developing use projections.
Supplementary Table S1 shows the countries that were considered
for this estimation exercise and initial assumptions about when
introduction of Sayana Press might start in each one.
On the basis of supporting infrastructure and estimated regulatory
approval timelines, it was assumed that countries could start introduc-
ing Sayana Press by the end of 2013 or the ﬁrst quarter of 2014. Regula-
tory approval at the country level is themost critical issuewith regard to
introduction startup; some of these anticipated timelines have shifted
since the present analysis was completed. The timing of product
introduction also has an impact on total consumption over time,
because a new user of the method is assumed to repeat her use every
three months, building total consumption over time.The follow-on stepwas estimation of the total population of women
of reproductive age in each of these countries. UN population data from
2010 and medium variant projections for 2015 and 2020 were used to
estimate the projected numbers of women of reproductive age for
2013 through 2016, assuming a uniform number of women entered
the cohort each year [11]. To estimate uptake and potential new users,
a two-step process was used. First, to identify the entire population of
women that year who “may” decide to use Sayana Press, the proportion
of women currently not using a contraceptive and who had stated an
intent to use injectables was applied to the total population of women
of reproductive age for that year. Data from themost recent Demographic
and Health Surveys (DHS) [12] for each of these countries were used to
provide ﬁgures on intention to use injectables. Where the DHS did not
give method-speciﬁc intent, the intent to use injectables was assumed
to have the same distribution as the percentage contribution of inject-
ables to current modern contraceptive prevalence rate. The next step in
the process assumed that, of this universe of “potential users,” a certain
percentage of stated intent to use converted to actual use. Two sets of as-
sumptions were used: a conservative set (assuming a lower rate of con-
version of stated intent to actual use) and an ambitious set (a higher
percent of stated intent converts to actual contraceptive use). The rate
of conversion of intent to use varied for both conservative and ambitious
estimates, depending onwhen the countrywould introduce the product.
For countries beginning later in the planning cycle, a steeper initial ramp-
up of product usewas assumed on the basis that experiences and lessons
learned in countries where introduction occurred earlier would be
shared. For each successive year, the number of newuserswas calculated
applying intent ﬁgures to the population of intending but current
non-users and adding the users of the previous year. Assumptions for
conversion of intent to use in each country are shown in Table 1.
Because calculations for new and underused methods routinely
overestimate demand [13], and the underlying objective was to
estimate order volumes, more stringent conservative assumptions
around adoption and discontinuation rates for the new method were
used. Using data from DHS around discontinuation of injectables, it
was estimated that about half the cohort of users of Sayana Press in a
given year would discontinue use of the product within or by the end
of the second year. Several other assumptions were embedded in the
calculations: (1) there would be no replacement of existing users of
any contraceptive method, especially injectables, with Sayana Press;
(2) the resources necessary for a countrywide introduction would be
available, including training, demand creation, and ensuring a supply
of the product; (3) in estimating the units of Sayana Press needed for
the year, all users in a country were assumed to have uniformly started
at the same time of the year; and (4) users of traditional methods were
classiﬁed as non-users for all intent conversion calculations.
Table 3
Ambitious estimates of units of Sayana Press.
Country Units
2013
Units
2014
Units
2015
Units
2016
Bangladesh 59 489 962 122 1 722 092 2 274 363
Burkina Faso 22 111 360 251 646 527 858 276
India (Bihar and Uttar Pradesh states) – 34 149 387 488 617 495
Indonesia – 834 800 4 677 059 7 330 204
Kenya 45 687 743 018 1 332 565 1 769 653
Madagascar – 104 809 595 352 947 879
Niger – 30 354 173 281 278 623
Nigeria – 245 115 1 392 053 2 224 489
Pakistan – 156 114 885 625 1 611 549
Senegal 8594 140 199 252 567 336 995
Sierra Leone – 20 685 117 085 186 028
Uganda 52 364 856 108 1 539 209 2 049 075
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The ﬁnal estimates for demand associated with countrywide intro-
ductions are shown in Tables 2 and 3. Even with the most conservative
assumptions, and assuming nomethod switching, Sayana Presswas esti-
mated to have the potential to reach between 0.3 million and 7 million
women in the three-year period between 2013 and 2016 in each of the
12 countries for which the projections were made. In the initial year of
introduction, projected numbers of clients reached—and volumes
achieved—were uniformly low. However by 2016, under the conserva-
tive assumptions used, up to 3 million would be reached depending on
theﬁnal list of countries. For estimatesmade using themore “ambitious”
assumptions, this ﬁgure would be approximately 6 million women.
Projected volumes of units relate to both the population size and the
extent to which there is current use of injectables in the method mix,
which in turn inﬂuences peer perceptions and future intentions to use
a method. Bangladesh—which has a large population and a high propor-
tion of injectable use in the method mix—showed greater potential
uptake than did India, where current use of injectables is very low.
Volumes of uptake on the basis of these assumptions were high in
countries like Kenya and Uganda—where use of injectables dominates
the method mix—and Senegal and Burkina Faso—where use is low, but
awareness of the method and future intent to use is high.4. Discussion
On the basis of the present results, Sayana Press could reach between
3 million and 6 million women across 12 countries in three years, de-
pending on the assumptions used. The data suggest that Sayana Press
has potential for countries looking to expand their contraceptive choices,
provisional to investments for service delivery infrastructure—especially
provider training—being available to support this demand.
We also compared these numbers to the growth in modern contra-
ceptive prevalence rates being proposed as part of metrics estimation
for the Family Planning 2020 summit. Lower-end estimates from the
models indicated that in the group of countries included in our
estimation, these hypothetical numbers would account for between
5% and 12% of modern contraceptive use (data not shown).
Our decision to use intent as a proxy for future usewas driven by the
fact that, although unmet need captures a normative need, it is a
synthetic construct derived mostly from stated fertility preferences
[14] and might not be strongly predictive of women’s future use of
contraception. Intent directly captures women’s stated preferences
about the use of contraception and thus could be a better predictor of
actual use [15]. The most comprehensive data to this end, from
Morocco, indicated nearly three-quarters of intent to use translating
into actual use within two years [16]. We chose to use much more con-
servative estimates of uptake even among the population with intent.Table 2
Conservative estimates of units of Sayana Press.
Country Units
2013
Units
2014
Units
2015
Units
2016
Bangladesh 8328 323 319 796 730 1 327 534
Burkina Faso 3096 121 579 301 481 506 964
India (Bihar and Uttar Pradesh states) – 27 319 194 059 365 729
Indonesia – 333 920 2 344 683 4 355 726
Kenya 6396 250 502 620 226 1 042 599
Madagascar – 41 924 299 324 566 182
Niger – 12 142 86 966 165 760
Nigeria – 98 046 697 996 1 321 260
Pakistan – 62 446 443 833 970 693
Senegal 1203 47 234 117 284 197 665
Sierra Leone – 8274 58 772 110 777
Uganda 7331 289 370 719 658 1 214 964Intent also allowed the capture of many unmeasured demand-side
variables in the projections that can vary from country to country. As
countries remove method-speciﬁc intent from their DHS, a valuable
indicator of future use might not be available. However, as can be seen
from the present results, use of a certain method and its popularity or
otherwise in a country’s method mix affects both awareness of that
method, and women’s experiences affect their peers' intent to use that
method in the future.
There are certainweaknesses inherent in themethodology given the
use of data that could be fairly dated for some countries. Fertility inten-
tions, contraceptive use, and intent data were assumed not to have
changed since the last DHS, which could have failed to capture secular
trends. A uniformly low rate of conversion of intent to actual use across
countries was assumed, and, while this was done assuming uniform in-
vestments in supply-side issues, countries/markets in which there is al-
ready existing use of intramuscular DMPA will require less intensive
investment in demand creation for Sayana Press.
Despite its limitations, the demand forecasting methods used in the
present study could prove useful for modeling demand estimates,
especially product extensions introduced in family planning programs,
particularly when comparisons “across the board” are needed.
5. Project updates
These initial demand estimates were prepared in 2012–13 and
reﬂect the situation as it was then expected in terms of timelines, etc.
As the process evolved and candidate countries for initial introduction
were identiﬁed, demand and consumption estimates were expected to
be revised as more speciﬁc introduction information became available
about the selection of the ﬁnal countries (Burkina Faso, Niger, Uganda,
Senegal and potentially Bangladesh), speciﬁc geographic locations
within countries, and speciﬁc delivery channels (number of providers,
extent of community-based delivery based on local policies, etc.).
Additionally, the process has been shaped by changes in regulatory
timelines, time to approvals, and a divergence from administrative
and logistic timelines initially envisaged. As country-speciﬁc strategies
were drawn up, pilot introductions—rather than the nationwide prod-
uct introductions—emerged as a preferred step in the selected countries.
In-country preferences and shifting donor priorities resulted in varying
choice of introduction channels (e.g. an estimated ﬁxed initial order for
social marketing in Bangladesh and community-based distribution in
Uganda). In scenarios where higher-level, higher-volume facilities
would be holding the product for distribution by outreach workers, it
was felt necessary to account for some unintended use at the facility
to ensure availability of product to the clients who need it most. Given
discrete funding for training, the numbers of providers and women
reached per provider are ﬁnite. The cumulative estimate for units
(including those needed for training, etc.) for a limited introduction
across ﬁve settings was estimated at approximately 4.2 million units.
As countries scale-up use of the method, we would have a better
E24 S. Khan et al. / International Journal of Gynecology and Obstetrics 130 (2015) E21–E24opportunity to compare projected results from the models in this exer-
cise with actual uptake and reﬁne the model with a view to improving
validity.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ijgo.2015.03.020.
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